The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection
Catherine WeatherediD, Kelly M. PenningtoniD, Patricio EscalanteiD, Elsje PienaariD
Abstract
Mycobacterium avium complex (MAC), is known for colonizing and infecting humans following inhalation of the bacteria. MAC pulmonary disease is notoriously difficult to treat and prone to recurrence. Both the incidence and prevalence MAC pulmonary disease have been increasing globally. MAC is well known to form biofilms in the environment, and in vitro, these biofilms have been shown to aid MAC in epithelial cell invasion, protect MAC from phagocytosis, and cause premature apoptosis in macrophages. In vivo, the system of interactions between MAC, biofilms and host macrophages is complex, difficult to replicate in vitro and in animal models, has not been fully characterized. Here we present a three-dimensional agent-based model of a lung airway to help understand how these interactions evolve in the first 14 days post-bacterial inhalation. We parameterized the model using published data and performed uncertainty analysis to characterize outcomes and parameters effects on those outcomes. Model results show diverse outcomes, including wide ranges of macrophage recruitment levels, and bacterial loads and phenotype distribution. Though most bacteria are phagocytosed by macrophages and remain intracellular, there are also many simulations in which extracellular bacteria continue to drive the colonization and infection. Initial parameters dictating host immune levels, bacterial loads introduced to the airway, and biofilm conditions have significant and lasting impacts on the course of these results. Additionally, though macrophage recruitment is key for suppressing bacterial loads, there is evidence of significant excess recruitment that fail to impact bacterial numbers. These results highlight a need and identify a path for further exploration into the inhalation events in MAC infection. Early infection dynamics could have lasting impacts on the development of nodular bronchiectatic or fibrocavitary disease as well as inform possible preventative and treatment intervention targeting biofilm-macrophage interactions.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 1.62
- Field percentile
- top 17%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemokine Signaling Caused by Mycobacterium avium Biofilms in the Lung Airway Increases Bacterial Loads by Spatially Diverting Macrophages
Catherine Weathered, Kelly M. Pennington, … Elsje Pienaar·bioRxiv·Sep 13, 2022
- A Marmoset Model for Mycobacterium avium Complex Pulmonary Disease
J. Peters, D. J. Maselli, … D. Griffith·bioRxiv·Nov 15, 2021
- Strain-dependent disease progression and necrotizing granuloma formation induced by virulent Mycobacterium avium complex strains in a murine model
Haruka Hikichi, Shiho Omori, … Naoto Keicho·Microbiology SpectrumPeer-reviewed·Mar 24, 2026
- Clinical isolates of Mycobacterium avium complex reveal an M. intracellulare-associated IL-17/neutrophilic pulmonary immune program in a murine disease model
Shintaro Seto, Koji Furuuchi, … Naoto Keicho·mSpherePeer-reviewed·Sep 21, 2026
- Macrophages reshape cytokine responses and bacterial spatial organization in an airway epithelial cell culture model
Alexander F. Melanson, Jenny Persson, … Helle Krogh Johansen·bioRxiv·May 30, 2026
- Dissemination and progression of pulmonary Mycobacterium avium infection in mouse model are associated with type 2 macrophage activation
R. Rosenbloom, I. Gavrish, … N. A. Crossland·bioRxiv·Jun 23, 2021